Value Sense
MOH
Molina Healthcare, Inc. (MOH)
Last Price$302.80.6%
Market Cap$17.3B
LTM Net Debt
($1,544.0M)
YoY Growth
-77.0%
3Y CAGR
-33.5%
5Y CAGR
-11.9%
Stock quality & Intrinsic value
6/10
37.0% undervalued
MOH
is 37.0% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Molina Healthcare, Inc. Net Debt

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Net Debt
($352.6M)
($440.1M)
($501.9M)
($377.0M)
($460.0M)
($562.6M)
($612.6M)
($875.7M)
($854.1M)
($1,671.2M)
($2,521.0M)
($2,932.0M)
($3,541.0M)
($3,049.0M)
($2,912.0M)
($3,677.0M)
($5,248.0M)
($5,114.0M)
($6,722.0M)
($5,869.0M)
MOH
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for MOH and see if it's the right time to invest.
Dive in

Molina Healthcare, Inc. (MOH) Net Debt comparison analysis

General

LTM Net Debt

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
($1,544.0M)
(77.0%)
(33.5%)
(11.9%)
Median Peer Set
($323.3M)
0.0%
0.0%
0.0%
CVS Health Corporation logo
CVS Health CorporationCVS
$71.9B
5.9%
4.3%
(2.3%)
Cigna Corporation logo
Cigna CorporationCI
$23.8B
19.7%
(5.0%)
(5.7%)
Centene Corporation logo
Centene CorporationCNC
$1,848.0M
N/A
(25.0%)
15.5%
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
$276.8M
N/A
N/A
N/A
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
($221.5M)
(5.7%)
(33.8%)
87.0%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
($425.0M)
187.1%
11.2%
N/A
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
($1,852.1M)
(18.1%)
3.1%
N/A
Elevance Health Inc. logo
Elevance Health Inc.ELV
($6,274.0M)
(43.1%)
(14.4%)
7.4%
Humana Inc. logo
Humana Inc.HUM
($8,714.0M)
N/A
N/A
N/A
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
($24.6B)
N/A
N/A
N/A

MOH key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
1,650.1
40.4%
2,005.0
21.5%
2,492.5
24.3%
3,112.4
24.9%
3,669.4
17.9%
4,086.0
11.4%
4,769.9
16.7%
6,028.8
26.4%
6,588.9
9.3%
9,666.6
46.7%
14,072.0
45.6%
17,711.0
25.9%
19,883.0
12.3%
18,890.0
(5.0%)
16,829.0
(10.9%)
19,423.0
15.4%
27,771.0
43.0%
31,974.0
15.1%
34,072.0
6.6%
40,650.0
19.3%
Cost of Goods Sold (COGS)1,424.91,678.72,080.12,621.33,176.23,449.54,004.05,397.05,713.68,616.112,434.015,941.018,003.016,266.014,394.016,746.024,491.028,048.029,738.00.0
Gross Profit
% margin
225.2
13.6%
326.3
16.3%
412.4
16.5%
491.1
15.8%
493.1
13.4%
636.5
15.6%
766.0
16.1%
631.8
10.5%
875.3
13.3%
1,050.5
10.9%
1,638.0
11.6%
1,770.0
10.0%
1,880.0
9.5%
2,624.0
13.9%
2,435.0
14.5%
2,677.0
13.8%
3,280.0
11.8%
3,926.0
12.3%
4,334.0
12.7%
40,650.0
100.0%
Operating Expenses179.4250.5314.0378.4437.3531.5621.2596.3738.7857.61,251.01,532.01,731.01,432.01,385.01,599.02,260.02,545.02,761.038,943.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)163.3229.1285.3344.8399.1346.0415.9532.6666.0764.71,147.01,393.01,594.01,333.01,296.01,480.02,068.02,311.02,462.02,743.0
Operating Income
% margin
45.8
2.8%
75.8
3.8%
98.3
3.9%
112.6
3.6%
57.4
1.6%
105.0
2.6%
80.2
1.7%
35.5
0.6%
136.6
2.1%
192.9
2.0%
387.0
2.8%
238.0
1.3%
(555.0)
(2.8%)
1,131.0
6.0%
1,044.0
6.2%
1,078.0
5.6%
1,020.0
3.7%
1,173.0
3.7%
1,573.0
4.6%
1,707.0
4.2%
Interest Income0.00.00.00.00.00.00.00.00.10.00.00.00.00.087.0102.0120.0110.00.00.0
Interest Expense0.00.04.68.713.815.515.516.852.156.867.0101.0118.0115.087.0102.0120.0110.0109.0118.0
Pre-tax Income43.973.593.7103.943.689.564.719.181.1135.3322.0137.0(612.0)999.0972.0961.0875.01,063.01,464.01,589.0
Income Tax
% effective tax rate
16.3
37.1%
27.7
37.8%
35.4
37.7%
41.5
39.9%
12.7
29.2%
34.5
38.6%
43.8
67.8%
9.3
48.6%
36.3
44.8%
72.7
53.8%
179.0
55.6%
129.0
94.2%
(100.0)
16.3%
292.0
29.2%
235.0
24.2%
288.0
30.0%
216.0
24.7%
271.0
25.5%
373.0
25.5%
410.0
25.8%
Net Income
% margin
27.6
1.7%
45.7
2.3%
58.3
2.3%
62.4
2.0%
30.9
0.8%
55.0
1.3%
20.8
0.4%
9.8
0.2%
52.9
0.8%
62.2
0.6%
143.0
1.0%
8.0
0.0%
(512.0)
(2.6%)
707.0
3.7%
737.0
4.4%
673.0
3.5%
659.0
2.4%
792.0
2.5%
1,091.0
3.2%
1,179.0
2.9%
EPS0.671.091.371.500.791.340.450.211.161.332.750.93(9.14)10.6111.8511.4111.4013.7018.7120.43
Diluted EPS0.651.081.371.500.791.320.450.211.131.292.580.92(9.14)10.5511.4811.2411.2513.5418.7820.43
EBITDA
% margin
60.9
3.7%
97.3
4.9%
126.3
5.1%
146.3
4.7%
94.0
2.6%
165.8
4.1%
210.2
4.4%
118.3
2.0%
214.1
3.2%
332.7
3.4%
514.0
3.7%
488.0
2.8%
(316.0)
(1.6%)
1,241.0
6.6%
1,148.0
6.8%
1,151.0
5.9%
1,126.0
4.1%
1,349.0
4.2%
1,744.0
5.1%
1,893.0
4.7%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Molina Healthcare, Inc.'s Net Debt?

As of today, Molina Healthcare, Inc.'s last 12-month Net Debt is ($1,544.0M), based on the financial report for Dec 31, 2024 (Q4’2024).

2) What is Molina Healthcare, Inc.'s Net Debt growth rate?

Over the last year, Molina Healthcare, Inc.'s Net Debt growth was (77.0%). The average annual Net Debt growth rates for Molina Healthcare, Inc. have been (30.0%) over the past three years, (11.9%) over the past five years.

3) Is Molina Healthcare, Inc.'s Net Debt growth rate Good?

Over the last year, Molina Healthcare, Inc.'s Net Debt growth was (77.0%), which is lower than industry growth of 1.0%. It indicates that Molina Healthcare, Inc.'s Net Debt growth is Good.

4) How does Molina Healthcare, Inc.'s Net Debt growth rate compare to its peers?

Over the last year, Molina Healthcare, Inc.'s Net Debt growth was (77.0%), which is lower than peer median growth of 99.8%. The list of peers includes CVS, CI, CNC, BHG, CLOV, ALHC, OSCR, ELV, HUM, UNH etc.